FinVector Oy – FDA 483
FinVector Oy, a drug substance and drug product manufacturer in Kuopio, Finland, was inspected and found to have significant deficiencies across its quality system. Key issues include inadequate Quality Assurance oversight, poorly defined quality procedures, inadequately qualified quality control assays, and deficiencies in aseptic operations, cleaning, and disinfection. The inspection also revealed problems with shipping validation, lack of procedures for commercial lot manufacturing, insufficient employee training, and inadequate management of GMP data.
- Company
- FinVector Oy
- Product type
- drugs
ID · aedbde8d-a25b-44a7-b6b2-7536a0dad18d
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.